VC FundEIF
🇪🇺 BioMedInvest III L.P.
BioMedPartners AG · Multi-Country
Fund size
CHF 100M
Focus
Health & Bio
EIF sector
Life Science
About BioMedInvest III L.P.
BioMedInvest III L.P. is a healthcare venture capital fund managed by BioMedPartners AG of Basel, Switzerland, closed at CHF 100 million in 2018. It invests in early- to mid-stage private companies in Switzerland, Germany and neighbouring EU countries, typically taking board seats, and is backed by the European Investment Fund as cornerstone investor. Initial investments included Cardior Pharmaceuticals and Amal Therapeutics.
EUACC IntelligenceFree preview
EUACC Intelligence
Ask about BioMedInvest III L.P.
Get instant answers about BioMedInvest III L.P. and how it fits your raise.